<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i> -Amplified Esophagogastric Cancer

Francisco Sánchez-Vega, Yelena Y. Janjigian, Pau Castel et al.|Cancer Discovery|2018

Cited by 147